The Enterprise Value as of December 2025 (TTM) for Niagen Bioscience Inc (NAGE) is 477.67M

According to Niagen Bioscience Inc’s latest financial reports and current stock price. The company's current Enterprise Value is 477.67M. This represents a change of -15.08% compared to the average of 562.50M of the last 4 quarters.

Niagen Bioscience Inc (NAGE) Historical Enterprise Value (quarterly & annually)

How has NAGE Enterprise Value performed in the past?

The mean historical Enterprise Value of Niagen Bioscience Inc over the last ten years is 198.23M. The current 477.67M Enterprise Value has changed 24.00% with respect to the historical average. Over the past ten years (40 quarters), NAGE's Enterprise Value was at its highest in in the June 2025 quarter at 1.08B. The Enterprise Value was at its lowest in in the September 2022 quarter at 75.38M.

Niagen Bioscience Inc (NAGE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Niagen Bioscience Inc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Niagen Bioscience Inc (NAGE) Average Enterprise Value

How has NAGE Enterprise Value performed in the past?

The current Enterprise Value of Niagen Bioscience Inc (NAGE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Niagen Bioscience Inc (NAGE) Enterprise Value vs. Peers

How is NAGE’s Enterprise Value compared to its peers?

Niagen Bioscience Inc’s Enterprise Value is less than Olema Pharmaceuticals, Inc. (1.86B), less than Corvus Pharmaceuticals, Inc. (655.78M), greater than Prothena Corporation plc (278.98M), less than Ventyx Biosciences, Inc. (548.92M), greater than Keros Therapeutics, Inc. (145.67M), greater than Akebia Therapeutics, Inc. (468.78M), less than Rigel Pharmaceuticals, Inc. (857.90M), less than Zevra Therapeutics, Inc. (502.08M), less than REGENXBIO Inc. (674.74M), less than KalVista Pharmaceuticals, Inc. (710.80M),

Build a custom stock screener for Niagen Bioscience Inc (NAGE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Niagen Bioscience Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Niagen Bioscience Inc (NAGE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Niagen Bioscience Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.